Robert Heald

Rob is a seasoned Medicinal Chemist and drug discovery expert with over 20 years of industrial experience.

Before joining Artios Rob was a Director of Chemistry at Argenta Discovery (latterly Charles River) where he managed a group of over 30 chemists and led teams and projects in collaborations with a wide range of institutions from Universities to large Biotech and Pharma. These collaborations included 10 years with Genentech and 5 years with Chiesi. During this time his teams were responsible for the discovery of 6 clinical candidates for oncology and respiratory indications, the most advanced of which is now in Phase III clinical studies.

Since joining Artios in 2016 shortly after Series A fundraising Rob has led the medicinal chemistry team responsible for delivering the first human DNA polymerase inhibitor to enter clinical trials, ART4215.